This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McDonald, T. L. Articles by Talmadge, J. E. Search for Related Content PubMed PubMed Citation Articles by McDonald, T. L. Articles by Talmadge, J. E.

Comparison of Antibody Isotypes in Sera and Circulating Immune Complexes during Tumor Growth and Metastasis of Three Tumor Models in Mice¹

University of Nebraska Medical Center, Department of Medical Microbiology, Omaha, Nebraska 68105 [T. L. M.], and Preclinical Screening Laboratory, NCI-Frederick Cancer Research Facility, Frederick, Maryland 21701 [M. C., J. E. T.]

The sera and circulating immune complexes (CICs) from mice bearing either UV-2237 mm, K-1735 M2, or B16-BL6 were analyzed for antibody isotype distribution during primary tumor growth and spontaneous metastasis. These studies clearly demonstrate that elevated CIC concentrations parallel the initial stages of primary tumor growth; however, the CICs, as well as serum concentration of all immunoglobulin G isotypes, rapidly decrease to near normal levels in the presence of heavy tumor burden. Following resection of the primary footpad tumor, increases in CIC levels paralleled outgrowth of metastasis; however, the antibody content of the CICs was isotypically restricted to immunoglobulin G2b and immunoglobulin G3 regardless of the tumor type. The immunoglobulin G isotype content of the CICs did not correspond to elevations in the serum concentrations of each respective isotype during neither primary nor metastatic tumor growth. This serial study indicates that the use of non-antigen-specific assays for CICs without regard to tumor burden or possible antibody isotypic restriction may be misleading, and that CIC levels can indeed correlate with metastatic tumor burden.

¹ This project has been funded, at least in part, with Federal funds from the Department of Health and Human Services, under Contract NO1-CO-23910 with Program Resources, Inc. The contents of this publication do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Govemment.

² To whom requests for reprints should be addressed, at University of Nebraska Medical Center, Department of Medical Microbiology, 42nd and Dewey, Omaha, NE 68105.

Received 1/27/84. Accepted 7/16/84.